The cost-effectiveness of chemoprophylaxis with Maloprim administered by primary health care workers in preventing death from malaria amongst rural Gambian children aged less than five years old.
In recent trials in The Gambia, mass chemoprophylaxis with Maloprim administered over several years by primary health care workers to children aged 3-59 months has reduced both mortality and morbidity without inducing impairment of natural immunity or significant development of drug resistance. Taking expenditure of both time and money, by both public authorities and village volunteers, into account, the costs and the cost effectiveness of such mass chemoprophylaxis are estimated here. The cost per child protected per season was (1990 US) $2.84; the cost per childhood death averted was $143. Both costs compare favourably with those of permethrin bed net impregnation. So in some circumstances where malaria is holoendemic, control of childhood malaria by chemoprophylaxis may be more economically efficient than provision of impregnated bed nets.
Picard
J
J
London School of Hygiene and Tropical Medicine, UK.
Mills
A
A
Greenwood
B
B
D000962:Antimalarials / Q000191:economics* / Q000627:therapeutic use; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003622:Dapsone / Q000191:economics* / Q000627:therapeutic use; D004338:Drug Combinations; D005714:Gambia; D006801:Humans; D007223:Infant; D008288:Malaria / Q000401:mortality / Q000517:prevention & control*; D011320:Primary Health Care / Q000191:economics; D011739:Pyrimethamine / Q000191:economics* / Q000627:therapeutic use; D012424:Rural Population
D000962:Antimalarials; D004338:Drug Combinations; C001678:Maloprim; D003622:Dapsone; D011739:Pyrimethamine